- Home
- ALTO vs RCKT Comparison
ALTO vs RCKT Comparison
Compare ALTO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALTO | RCKT |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | United States | United States |
| Employees | N/A | 202 |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.2M | 401.6M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALTO | RCKT |
|---|---|---|
| Price | $5.71 | $3.05 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $29.73 |
| AVG Volume (30 Days) | ★ 2.3M | 2.0M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 119.51 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $917,927,000.00 | N/A |
| Revenue This Year | $6.66 | N/A |
| Revenue Next Year | $0.43 | $64.28 |
| P/E Ratio | $108.30 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $2.40 |
| 52 Week High | $6.00 | $5.45 |
Technical Indicators
Market Signals| Indicator | ALTO | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 64.51 | 38.13 |
| Support Level | $4.27 | $2.96 |
| Resistance Level | $6.00 | $3.52 |
| Average True Range (ATR) | 0.33 | 0.18 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 83.56 | 17.78 |
Price Performance
Historical ComparisonAbout ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.